Since NDA’s inception in 1997, we have been supporting clients with a great variety of regulatory drug development needs, across all therapeutic areas. Our clients come to us for advice on their programs and for our support to successfully execute them.
We pride ourselves on the great quality of our services and the value we bring to pharmaceutical companies and patients.
In early 2016 NDA merged with PharmApprove – the scientific communications firm in the US, world leaders in preparations and management of successful FDA Advisory Committee Meetings.
This expanded our client base and increased our capabilities to support our clients need to manage their programs from a US perspective.